CAW
BMY icon

Cornerstone Advisors (Washington)’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$670K Sell
11,106
-16
-0.1% -$963 0.07% 32
2020
Q2 		$654K Buy
11,122
+1,157
+12% +$69.2K 0.07% 29
2020
Q1 		$555K Sell
9,965
-350
-3% -$21.4K 0.08% 30
2019
Q4 		$662K Buy
10,315
+2,452
+31% +$140K 0.08% 31
2019
Q3 		$399K Buy
7,863
+833
+12% +$39.1K 0.05% 46
2019
Q2 		$319K Buy
7,030
+441
+7% +$20.5K 0.03% 92
2019
Q1 		$314K Sell
6,589
-224
-3% -$11.2K 0.03% 86
2018
Q4 		$354K Sell
6,813
-1,181
-15% -$63.5K 0.06% 64
2018
Q3 		$496K Buy
7,994
+114
+1% +$6.76K 0.32% 48
2018
Q2 		$436K Buy
7,880
+65
+0.8% +$3.51K 0.3% 56
2018
Q1 		$494K Buy
7,815
+629
+9% +$40.5K 0.34% 46
2017
Q4 		$440K Sell
7,186
-9
-0.1% -$563 0.29% 50
2017
Q3 		$459K Sell
7,195
-351
-5% -$20.5K 0.32% 46
2017
Q2 		$420K Sell
7,546
-486
-6% -$26.4K 0.23% 48
2017
Q1 		$437K Buy
8,032
+494
+7% +$27.1K 0.24% 46
2016
Q4 		$441K Buy
7,538
+709
+10% +$38.8K 0.37% 38
2016
Q3 		$368K Buy
6,829
+3,743
+121% +$240K 0.31% 42
2016
Q2 		$227K Sell
3,086
-335
-10% -$23.7K 0.23% 54
2016
Q1 		$219K Sell
3,421
-563
-14% -$35.5K 0.23% 55
2015
Q4 		$274K Sell
3,984
-2,327
-37% -$154K 0.3% 36
2015
Q3 		$374K Buy
6,311
+193
+3% +$12.2K 0.33% 38
2015
Q2 		$407K Hold
6,118
– – 0.33% 47
2015
Q1 		$395K Buy
6,118
+261
+4% +$16.3K 0.31% 51
2014
Q4 		$346K Buy
5,857
+4,758
+433% +$268K 0.25% 68
2014
Q3 		$56K Sell
1,099
-39
-3% -$1.95K 0.05% 71
2014
Q2 		$55K Hold
1,138
– – 0.05% 84
2014
Q1 		$59K Buy
1,138
+951
+509% +$50.6K 0.07% 72
2013
Q4 		$10K Buy
187
+12
+7% +$611 0.01% 142
2013
Q3 		$8K Buy
175
+12
+7% +$527 0.01% 147
2013
Q2 		$7K Buy
+163
New +$7.08K 0.02% 103

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Cornerstone Advisors (Washington)'s BMY Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Bristol-Myers Squibb (BMY) stake by 0.14% in Q3 2020, selling an estimated $963 and leaving 11,106 shares worth $670K. The position accounts for 0.07% of the portfolio, ranked #32.

Cornerstone Advisors (Washington) first reported a position in BMY in Q2 2013 and has held it in 30 quarters since. 2,215 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • Cornerstone Advisors (Washington) held 11,106 shares of Bristol-Myers Squibb worth $670K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 16 Bristol-Myers Squibb shares in Q3 2020, an estimated $963.
  • Bristol-Myers Squibb made up 0.07% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #32 holding.
  • Cornerstone Advisors (Washington) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 30 quarters since.
  • 2,215 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.